Pharmacokinetic Changes during Pregnancy According to Genetic Variants: A Prospective Study in HIV-infected Patients Receiving Atazanavir/Ritonavir

Emanuele Focà; Andrea CALCAGNO; Andrea Bonito; Jessica Cusato; Elisabetta Domenighini; Antonio D'Avolio; Eugenia Quiros Roldan; Laura Trentini; Filippo Castelnuovo; Giovanni Di Perri; Francesco Castelli; Stefano Bonora

doi:10.1128/AAC.00309-18

Pharmacokinetic Changes during Pregnancy According to Genetic Variants: A Prospective Study in HIV-infected Patients Receiving Atazanavir/Ritonavir

Emanuele Focà
, Andrea CALCAGNO
, Andrea Bonito
, Jessica Cusato
, Elisabetta Domenighini
, Antonio D'Avolio
, Eugenia Quiros Roldan
, Laura Trentini
, Filippo Castelnuovo
, Giovanni Di Perri
, Francesco Castelli
, Stefano Bonora

Dipartimento di Medicina Traslazionale

Risultato della ricerca: Contributo su rivista › Articolo in rivista › peer review

Abstract

Atazanavir/ritonavir concentrations change over pregnancy in HIV-positive patients; the impact of genetic variants is unknown. 20 patients were enrolled: antiretrovirals' plasma and intracellular concentrations were measured in addition to single nucleotide polymorphisms in transport affecting genes. Linear logistic regression showed that genetic variants in organic-anion-transporter-1B1 and pregnane-X-receptor encoding genes affected third trimester atazanavir exposure. In this prospective study genetic variants partially explained the observed inter-patient variability in third-trimester antiretrovirals' exposure.

Lingua originale	Inglese
pagine (da-a)	1-5
Numero di pagine	5
Rivista	Antimicrobial Agents and Chemotherapy
Volume	1
Numero di pubblicazione	1
DOI	https://doi.org/10.1128/AAC.00309-18
Stato di pubblicazione	Pubblicato - 2018

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

SDG 3 Salute e benessere

Accesso al documento

10.1128/AAC.00309-18

https://hdl.handle.net/11579/217001

Altri file e collegamenti

handle

Cita questo

Focà, E., CALCAGNO, A., Bonito, A., Cusato, J., Domenighini, E., D'Avolio, A., Roldan, E. Q., Trentini, L., Castelnuovo, F., Perri, G. D., Castelli, F., & Bonora, S. (2018). Pharmacokinetic Changes during Pregnancy According to Genetic Variants: A Prospective Study in HIV-infected Patients Receiving Atazanavir/Ritonavir. Antimicrobial Agents and Chemotherapy, 1(1), 1-5. https://doi.org/10.1128/AAC.00309-18

@article{8c07cc2e8ed04fb69098db8c6bf37f09,

title = "Pharmacokinetic Changes during Pregnancy According to Genetic Variants: A Prospective Study in HIV-infected Patients Receiving Atazanavir/Ritonavir",

abstract = "Atazanavir/ritonavir concentrations change over pregnancy in HIV-positive patients; the impact of genetic variants is unknown. 20 patients were enrolled: antiretrovirals' plasma and intracellular concentrations were measured in addition to single nucleotide polymorphisms in transport affecting genes. Linear logistic regression showed that genetic variants in organic-anion-transporter-1B1 and pregnane-X-receptor encoding genes affected third trimester atazanavir exposure. In this prospective study genetic variants partially explained the observed inter-patient variability in third-trimester antiretrovirals' exposure.",

author = "Emanuele Foc{\`a} and Andrea CALCAGNO and Andrea Bonito and Jessica Cusato and Elisabetta Domenighini and Antonio D'Avolio and Roldan, \{Eugenia Quiros\} and Laura Trentini and Filippo Castelnuovo and Perri, \{Giovanni Di\} and Francesco Castelli and Stefano Bonora",

year = "2018",

doi = "10.1128/AAC.00309-18",

language = "English",

volume = "1",

pages = "1--5",

journal = "Antimicrobial Agents and Chemotherapy",

issn = "0066-4804",

publisher = "American Society for Microbiology",

number = "1",

}

Focà, E, CALCAGNO, A, Bonito, A, Cusato, J, Domenighini, E, D'Avolio, A, Roldan, EQ, Trentini, L, Castelnuovo, F, Perri, GD, Castelli, F & Bonora, S 2018, 'Pharmacokinetic Changes during Pregnancy According to Genetic Variants: A Prospective Study in HIV-infected Patients Receiving Atazanavir/Ritonavir', Antimicrobial Agents and Chemotherapy, vol. 1, n. 1, pagg. 1-5. https://doi.org/10.1128/AAC.00309-18

TY - JOUR

T1 - Pharmacokinetic Changes during Pregnancy According to Genetic Variants: A Prospective Study in HIV-infected Patients Receiving Atazanavir/Ritonavir

AU - Focà, Emanuele

AU - CALCAGNO, Andrea

AU - Bonito, Andrea

AU - Cusato, Jessica

AU - Domenighini, Elisabetta

AU - D'Avolio, Antonio

AU - Roldan, Eugenia Quiros

AU - Trentini, Laura

AU - Castelnuovo, Filippo

AU - Perri, Giovanni Di

AU - Castelli, Francesco

AU - Bonora, Stefano

PY - 2018

Y1 - 2018

N2 - Atazanavir/ritonavir concentrations change over pregnancy in HIV-positive patients; the impact of genetic variants is unknown. 20 patients were enrolled: antiretrovirals' plasma and intracellular concentrations were measured in addition to single nucleotide polymorphisms in transport affecting genes. Linear logistic regression showed that genetic variants in organic-anion-transporter-1B1 and pregnane-X-receptor encoding genes affected third trimester atazanavir exposure. In this prospective study genetic variants partially explained the observed inter-patient variability in third-trimester antiretrovirals' exposure.

AB - Atazanavir/ritonavir concentrations change over pregnancy in HIV-positive patients; the impact of genetic variants is unknown. 20 patients were enrolled: antiretrovirals' plasma and intracellular concentrations were measured in addition to single nucleotide polymorphisms in transport affecting genes. Linear logistic regression showed that genetic variants in organic-anion-transporter-1B1 and pregnane-X-receptor encoding genes affected third trimester atazanavir exposure. In this prospective study genetic variants partially explained the observed inter-patient variability in third-trimester antiretrovirals' exposure.

UR - https://iris.uniupo.it/handle/11579/217001

U2 - 10.1128/AAC.00309-18

DO - 10.1128/AAC.00309-18

M3 - Article

SN - 0066-4804

VL - 1

SP - 1

EP - 5

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

IS - 1

ER -

Pharmacokinetic Changes during Pregnancy According to Genetic Variants: A Prospective Study in HIV-infected Patients Receiving Atazanavir/Ritonavir

Abstract

OSS delle Nazioni Unite

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo